Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Asahi Kasei Corporate Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 7
Rounds per year 0.50
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Industrial Supplies and Parts
  • AgTech
  • Agriculture
Summary

Asahi Kasei Corporate Venture Capital is the famous VC, which was founded in 2008. The venture was found in North America in United States. The main office of represented VC is situated in the Menlo Park.

Among the most popular fund investment industries, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Feldan Therapeutics, Hazel Technologies. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Asahi Kasei Corporate Venture Capital, startups are often financed by Valley Oak Investments, Rhapsody Venture Partners, VentureWell. The meaningful sponsors for the fund in investment in the same round are Valley Oak Investments, Stonebridge Ventures, Serra Ventures. In the next rounds fund is usually obtained by National Institutes of Health.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Asahi Kasei Corporate Venture Capital:
Typical Co-investors
Asahi Kasei Corporate Venture Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Asahi Kasei Corporate Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Yisheng Innovation Technology Beijing, Beijing, China
CCIAA Pisa -
DIventures Switzerland, Zürich, Zurich
InterVest Co. Seoul, Seoul-t'ukpyolsi, South Korea
Kitara Capital Masqat, Muscat, Oman
Lasa Qianrui -
Mad'a Investment Company Ar Riyad, Riyadh, Saudi Arabia
Open Source Syndicate California, San Francisco, United States
Shanghai Shangchuang Xinwei Investment Management -
Steadfast Financial New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Swing Therapeutics

Biotechnology
Therapeutics
$10M16 Jun 2022 San Francisco, California, United States

Koya Medical

Biotechnology
Health Care
Internet
Pharmaceutical
$26M03 Feb 2022 Oakland, California, United States

Hazel Technologies

Agriculture
AgTech
Biotechnology
Industrial Supplies and Parts
Other Agriculture
$70M13 Apr 2021 Chicago, Illinois, United States

Computer
Software
$55M24 Mar 2021 Redwood City, California, United States

Dami&Xiaomi

Health Care
Training
Wellness
$1M18 Nov 2020 Futian District, Guangdong Province, China

Hazel Technologies

Agriculture
AgTech
Biotechnology
Industrial Supplies and Parts
Other Agriculture
$13M12 Aug 2019 Chicago, Illinois, United States

Feldan Therapeutics

Biotechnology
Therapeutics
$13M18 Sep 2018 Quebec

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Asahi Kasei Corporate Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 26M
Rounds per year 0.50
Peak activity year 2021
Lead investments 0
Follow on index 0.12
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Swing Therapeutics

Biotechnology
Therapeutics
$10M16 Jun 2022 San Francisco, California, United States

Koya Medical

Biotechnology
Health Care
Internet
Pharmaceutical
$26M03 Feb 2022 Oakland, California, United States

Hazel Technologies

Agriculture
AgTech
Biotechnology
Industrial Supplies and Parts
Other Agriculture
$70M13 Apr 2021 Chicago, Illinois, United States

Computer
Software
$55M24 Mar 2021 Redwood City, California, United States

Dami&Xiaomi

Health Care
Training
Wellness
$1M18 Nov 2020 Futian District, Guangdong Province, China

Hazel Technologies

Agriculture
AgTech
Biotechnology
Industrial Supplies and Parts
Other Agriculture
$13M12 Aug 2019 Chicago, Illinois, United States

Feldan Therapeutics

Biotechnology
Therapeutics
$13M18 Sep 2018 Quebec
Crunchbase icon

Content report

The following text will be sent to our editors: